Latest

Innovation and Unlikely Risks! What’s in Store for 2025?

Innovation and Unlikely Risks! What’s in Store for 2025?

December 22, 2024
As we edge closer to 2025, the focus shifts towards new sectors promising growth. While 2024 was all about the hardware boom, Analysts predict software stocks will dominate 2025. In particular, application makers like SoundHound AI and Palantir are expected to outpace
AstraZeneca Faces Turbulence. Is Now the Time to Invest?

AstraZeneca Faces Turbulence. Is Now the Time to Invest?

December 22, 2024
AstraZeneca, one of the U.K.’s leading pharmaceutical companies, is currently grappling with significant challenges in China. Recent arrest of the company’s top executives, including Leon Wang, the president of AstraZeneca China, has cast a shadow over its operations in this vital market.
1 471 472 473 474 475 937